Table 1.
Characteristic | Case patients |
Age at blood collection (y), mean (SD) | 64.4 (7.8) |
Age at diagnosis (y), mean (SD) | 69.5 (7.5) |
Stage, No. (%)† | |
T1, T2 (N0, M0) | 1010 (86) |
T3a (N0, M0) | 92 (8) |
T3b (N0, M0) | 43 (4) |
T4 (N0, M0) | 1 (0) |
N1 | 15 (1) |
M1 | 15 (1) |
Gleason grade, No. (%)‡ | |
2 to 6 | 646 (56) |
7: 3 + 4 or no major score defined | 275 (24) |
7: 4 + 3 | 110 (9) |
8 to 10 | 129 (11) |
Deaths or metastases due to prostate cancer, No. (%) | 114 (9) |
Prostate cancer deaths without recorded date of metastasis | 68 |
Metastases to bone or organs on follow-up | 31 |
Metastases at diagnosis | 15 |
Time to diagnosis from blood draw (y), median (IQR) | 5.2 (2.9–7.5) |
Time to lethal prostate cancer (death or metastases) from diagnosis (y), median (IQR) | 5.2 (3.1–8.4) |
IQR = interquartile range; SD = standard deviation.
Data for stage missing for 84 subjects.
Data for Gleason grade missing for 100 subjects.